-
Mount Sinai Medical Center, New York, New York
Chair
-
McGill University, Montreal, Canada
-
University at Buffalo, Buffalo, New York
-
Genentech-Roche, San Francisco, California
-
The University of Alabama at Birmingham School of Public Health, Birmingham, Alabama
-
Neurological Institute, Cleveland Clinic, Cleveland, Ohio
-
Novartis Pharmaceuticals, San Francisco, California
-
Mark Freedman, MD, CSPQ, FAAN, FRCP(C)
Ottawa Hospital Research Institute, Ottawa, Canada
-
National Multiple Sclerosis Society, New York, New York (until 2018)
-
Augusta MS Center, Augusta, Georgia
-
National Multiple Sclerosis Society, New York, New York
-
Ruth Ann Marrie, MD, PhD, FRCP(C)
University of Manitoba, Winnipeg, Canada
-
Advancing Research in MS, Buffalo, New York
-
Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (until 2018)
-
Novartis Pharmaceuticals, San Francisco, California
-
Brigham and Women's Hospital, Boston, Massachusetts
-
Robert Wood Johnson Medical School, New Brunswick, New Jersey
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
University Hospital of Basel, Basel, Switzerland
-
University of California San Francisco, San Francisco, California
-
The Ohio State University Medical Center, Columbus, Ohio
-
Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
Vice Chair
-
The Hospital for Sick Children, University of Toronto, Toronto, Canada
-
Brigham and Women's Hospital, Boston, Massachusetts
-
H?pital Neurologique Pierre Wertheimer, Bron, France
-
Teva Pharmaceuticals Industries Ltd, Petah Tikva, Israel
-
National Multiple Sclerosis Society, New York, New York
-
Kaiser Permanente Department of Research & Evaluation, Pasadena, California
-
Ruth Ann Marrie, MD, PhD, FRCP(C)
University of Manitoba, Winnipeg, Canada
-
University of Calgary, Calgary, Canada
-
Amgen, Thousand Oaks, California
-
William Pryse-Phillips, MD
Memorial University of Newfoundland, St. John's, Canada
-
University of British Columbia, Vancouver, Canada
-
Keck School of Medicine of University of Southern California, Los Angeles, California
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
Vice Chair
-
McGill University, Montreal, Canada
-
State University of New York at Stony Brook, Stony Brook, New York
-
Washington University School of Medicine, St. Louis, Missouri
-
Mark Freedman, MD, CSPQ, FAAN, FRCP(C)
Ottawa Hospital Research Institute, Ottawa, Canada
-
Robert Lisak, MD, FAAN, FRCP
Wayne State University School of Medicine, Detroit, Michigan
-
Business Partner-MD, Henderson, Nevada
-
University of California San Francisco, San Francisco, California
Vice Chair
-
Genentech-Roche, San Francisco, California
-
Hospital Center University Toulouse, Toulouse, France
-
Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
-
University of Plymouth, Plymouth, United Kingdom
-
University Hospital of Basel, Basel, Switzerland
-
Mount Sinai School of Medicine, New York, New York
-
Hospital Universitari Vall D'Hebron, Barcelona, Spain
-
University of Toronto, Toronto, Canada
-
Scientific and Clinical Review Associates LLC, Salisbury, Connecticut
-
Per Soelberg Sorensen, MD, DMsc, FAAN
Copenhagen University Hospital, Kobenhavn, Denmark
-
Emmanuelle Waubant, MD, PhD
University of California San Francisco, San Francisco, California
-
University of Texas Health Science Center at Houston, Houston, Texas
Chair
-
McGill University, Montreal, Canada
-
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
-
VU Medical Center Amsterdam, Amsterdam, The Netherlands
-
University Ospedale San Raffaele, Milano, Italy
-
Cleveland Clinic Lerner Research Institute, Cleveland, Ohio
-
Teva Pharmaceuticals Industries Ltd, Philadelphia, Pennsylvania
-
UCL Institute of Neurology, London, United Kingdom
-
Oregon Health and Sciences University, Portland, Oregon
-
University at Buffalo, Buffalo, New York
Chair
-
University of Florence, Florence, Italy
-
Novartis Pharmaceuticals, San Francisco, California
-
University of California San Francisco, San Francisco, California
-
Stony Brook University Hospital, Stony Brook, New York
-
Royal Holloway, University of London, Egham, United Kingdom
-
National Multiple Sclerosis Society, New York, New York
-
Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
-
Christine Till, PhD, Cpsych
York University, Toronto, Canada
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
M. Carolina Mendoza-Puccini, MD
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
NINDS CDE Project Officer, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
The Emmes Corporation
-
The Emmes Corporation
-
The Emmes Corporation
-
The Emmes Corporation
-
The Emmes Corporation
-
KAI Research, Inc. (An Altarum Company), Rockville, Maryland
-
KAI Research, Inc. (An Altarum Company), Rockville, Maryland
-
KAI Research, Inc. (An Altarum Company), Rockville, Maryland